ADCYAP1 and neurodegenerative disease: These findings highlight PACAP38 and PACAP6-38 as potent modulators of actin dynamics, potentially useful in therapeutic applications targeting cytoskeletal reorganization in neurodegenerative diseases and traumatic injuries.